André W. Broekmans

1.1k total citations
15 papers, 828 citations indexed

About

André W. Broekmans is a scholar working on Economics and Econometrics, Pediatrics, Perinatology and Child Health and Physiology. According to data from OpenAlex, André W. Broekmans has authored 15 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Economics and Econometrics, 4 papers in Pediatrics, Perinatology and Child Health and 3 papers in Physiology. Recurrent topics in André W. Broekmans's work include Health Systems, Economic Evaluations, Quality of Life (4 papers), Pharmaceutical Economics and Policy (4 papers) and Pharmaceutical studies and practices (4 papers). André W. Broekmans is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (4 papers), Pharmaceutical Economics and Policy (4 papers) and Pharmaceutical studies and practices (4 papers). André W. Broekmans collaborates with scholars based in Netherlands, United States and United Kingdom. André W. Broekmans's co-authors include Jan J. Veltkamp, Rogier M. Bertina, Richard A. Marlar, Robert R. Montgomery, Berthold P. R. Gersons, Jitschak G. Storosum, Barbara J. van Zwieten, Wim van den Brink, Olaf H. Klungel and Jarno Hoekman and has published in prestigious journals such as New England Journal of Medicine, American Journal of Psychiatry and Nature Reviews Drug Discovery.

In The Last Decade

André W. Broekmans

15 papers receiving 762 citations

Peers

Countries citing papers authored by André W. Broekmans

Since Specialization

Citations

This map shows the geographic impact of André W. Broekmans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André W. Broekmans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André W. Broekmans more than expected).

Fields of papers citing papers by André W. Broekmans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André W. Broekmans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André W. Broekmans. The network helps show where André W. Broekmans may publish in the future.

Co-authorship network of co-authors of André W. Broekmans

This figure shows the co-authorship network connecting the top 25 collaborators of André W. Broekmans. A scholar is included among the top collaborators of André W. Broekmans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André W. Broekmans. André W. Broekmans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Development and Regulation of Gene and Cell-Based Therapies in Europe: A Quantification and Reflection 2020 ·Trends in Pharmacological Sciences ·Renske M.T. ten Ham, Anke M. Hövels, Olaf H. Klungel, Hubert G. M. Leufkens, André W. Broekmans, Jarno Hoekman	5
2	The evolution of adaptiveness: balancing speed and evidence 2018 ·Nature Reviews Drug Discovery ·Hans‐Georg Eichler, Richard Barker, (unknown), Jacoline C. Bouvy, André W. Broekmans, Anna Bucsics, Francesca Cerreta, Solange Corriol‐Rohou, Alı́cia Granados, Yann Le Cam, Ad Schuurman	6
3	Challenges in Advanced Therapy Medicinal Product Development: A Survey among Companies in Europe 2018 ·Molecular Therapy — Methods & Clinical Development ·Renske M.T. ten Ham, Jarno Hoekman, Anke M. Hövels, André W. Broekmans, Hubert G.M. Leufkens, Olaf H. Klungel	72
4	Medicines Adaptive Pathways to Patients: Why, When, and How to Engage? 2018 ·Clinical Pharmacology & Therapeutics ·Hans‐Georg Eichler, (unknown), Mathieu Boudes, Jacoline C. Bouvy, André W. Broekmans, Francesca Cerreta, Stuart Faulkner, (unknown), (unknown), Yann Le Cam, (unknown), (unknown), Solange Corriol‐Rohou	7
5	Traceability of Biologics in The Netherlands: An Analysis of Information-Recording Systems in Clinical Practice and Spontaneous ADR Reports 2015 ·Drug Safety ·Kevin Klein, (unknown), (unknown), André W. Broekmans, Eugène van Puijenbroek, Marie L. De Bruin, Pieter Stolk	25
6	Classification of Recombinant Biologics in the EU: Divergence Between National Pharmacovigilance Centers 2015 ·BioDrugs ·Kevin Klein, Marie L. De Bruin, André W. Broekmans, Pieter Stolk	2
7	[The new pharmacovigilance legislation in practice]. 2014 ·PubMed ·André W. Broekmans, Peter G. M. Mol	1
8	Dr. Storosum and Colleagues Reply 2002 ·American Journal of Psychiatry ·Jitschak G. Storosum, Barbara J. van Zwieten, Wim van den Brink, Berthold P. R. Gersons, André W. Broekmans	1
9	Short-term efficacy of tricyclic antidepressants revisited: a meta-analytic study 2001 ·European Neuropsychopharmacology ·Jitschak G. Storosum, André Elferink, Barbara J. van Zwieten, Wim van den Brink, Berthold P. R. Gersons, R. van Strik, André W. Broekmans	52
10	Suicide Risk in Placebo-Controlled Studies of Major Depression 2001 ·American Journal of Psychiatry ·Jitschak G. Storosum, Barbara J. van Zwieten, Wim van den Brink, Berthold P. R. Gersons, André W. Broekmans	83
11	Assessment of biotechnology drugs: what are the issues? 1999 ·Health Policy ·(unknown), Hubert G. M. Leufkens, Daan J.A. Crommelin, (unknown), André W. Broekmans	15
12	Diagnosis and treatment of homozygous protein C deficiency 1989 ·The Journal of Pediatrics ·Richard A. Marlar, Robert R. Montgomery, André W. Broekmans, (unknown)	155
13	Report on the Diagnosis and Treatment of Homozygous Protein C Deficiency 1989 ·Thrombosis and Haemostasis ·Richard A. Marlar, Robert R. Montgomery, André W. Broekmans	73
14	Sequential Administration of Human and Porcine Factor VIII for Surgical Treatment of a Parotid Tumour in a Patient with a Factor VIII Inhibitor 1985 ·Acta Haematologica ·Ernest Briët, (unknown), (unknown), (unknown), Floris W.A. Otten, (unknown), André W. Broekmans	4
15	Congenital Protein C Deficiency and Venous Thromboembolism 1983 ·New England Journal of Medicine ·André W. Broekmans, Jan J. Veltkamp, Rogier M. Bertina	327

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact